Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 30, 2019

SELL
N/A
-54,822 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
N/A
-139,893 Reduced 71.85%
54,822 $468,000
Q3 2018

Nov 13, 2018

SELL
N/A
-7,400 Reduced 3.66%
194,715 $3.9 Million
Q2 2018

Aug 13, 2018

SELL
N/A
-40,800 Reduced 16.8%
202,115 $5.22 Million
Q1 2018

May 15, 2018

SELL
N/A
-27,600 Reduced 10.2%
242,915 $5.81 Million
Q4 2017

Feb 08, 2018

SELL
N/A
-63,000 Reduced 18.89%
270,515 $9.17 Million
Q3 2017

Nov 14, 2017

BUY
N/A
70,000 Added 26.56%
333,515 $7.06 Million
Q2 2017

Aug 10, 2017

BUY
N/A
263,515
263,515 $4.61 Million

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Granite Point Capital Management, L.P. Portfolio

Follow Granite Point Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.